HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor-associated trypsin inhibitor (TATI) in pleural effusions.

Abstract
The purpose of this study was to evaluate the usefulness of tumor-associated trypsin inhibitor (TATI) determination in serum and pleural fluid for differential diagnosis of relapsing pleural effusions. The concentrations of TATI were determined in samples of serum and pleural fluid from 51 patients with pleural effusions comprising 20 benign exudates, 5 transudates and 26 malignant effusions. TATI levels overlapped in benign and malignant fluids. This precludes the use of this marker for diagnosis of pleural effusions. For this purpose CEA seems to be the best tumor marker with a sensitivity frequently higher than that of cytology.
AuthorsM Rapellino, F Pecchio, S Baldi, M R Adamo, M Macri, G Ricardi
JournalScandinavian journal of clinical and laboratory investigation. Supplementum (Scand J Clin Lab Invest Suppl) Vol. 207 Pg. 47-9 ( 1991) ISSN: 0085-591X [Print] Norway
PMID1780690 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Carcinoembryonic Antigen
  • Trypsin Inhibitor, Kazal Pancreatic
Topics
  • Biomarkers, Tumor (analysis, blood)
  • Breast Neoplasms (chemistry, diagnosis)
  • Carcinoembryonic Antigen (analysis)
  • Diagnosis, Differential
  • Female
  • Humans
  • Lung Neoplasms (chemistry, diagnosis)
  • Pleural Effusion (diagnosis, metabolism)
  • Sensitivity and Specificity
  • Trypsin Inhibitor, Kazal Pancreatic (analysis, blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: